LMI is the maker of Neuraceq, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s

Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility. 

A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon? 

Authorities claim Stevie Adams, 35, of Las Vegas said he would shoot up the headquarters of Molina Healthcare, following a dispute. He has been charged for making terroristic threats. 

Diagnostic imaging leads the way in AI product approvals by a mile, accounting for more than 70% of all applications on the list. 

The companies argue that the U.S. Department of Justice has failed to adequately demonstrate how, and in which regions of the country, the merger would harm competition. They are asking a federal court to throw out the case.

Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.

The Medical Group Management Association made its demands in a letter to newly appointed leaders in the U.S. House and Senate sent Tuesday.